Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.
July 09, 2019 at 01:52 am
Hana Pharm Co., Ltd (KOSE:A293480) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of its shares pursuant to a trust contract with Mirae Asset Daewoo Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on January 8, 2020. As of July 8, 2019, the company had 178,551 shares in treasury within scope available for dividend and had no shares in treasury under other capacities.